Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub‐Saharan Africa: systematic review and meta‐analysis
Top Cited Papers
Open Access
- 20 September 2012
- journal article
- research article
- Published by Wiley in Tropical Medicine & International Health
- Vol. 17 (12), 1509-1520
- https://doi.org/10.1111/j.1365-3156.2012.03089.x
Abstract
Objectives To assess the proportion of patients lost to programme (died, lost to follow‐up, transferred out) between HIV diagnosis and start of antiretroviral therapy (ART) in sub‐Saharan Africa, and determine factors associated with loss to programme. Methods Systematic review and meta‐analysis. We searched PubMed and EMBASE databases for studies in adults. Outcomes were the percentage of patients dying before starting ART, the percentage lost to follow‐up, the percentage with a CD4 cell count, the distribution of first CD4 counts and the percentage of eligible patients starting ART. Data were combined using random‐effects meta‐analysis. Results Twenty‐nine studies from sub‐Saharan Africa including 148 912 patients were analysed. Six studies covered the whole period from HIV diagnosis to ART start. Meta‐analysis of these studies showed that of the 100 patients with a positive HIV test, 72 (95% CI 60–84) had a CD4 cell count measured, 40 (95% CI 26–55) were eligible for ART and 25 (95% CI 13–37) started ART. There was substantial heterogeneity between studies (P < 0.0001). Median CD4 cell count at presentation ranged from 154 to 274 cells/μl. Patients eligible for ART were less likely to become lost to programme (25%vs. 54%, P < 0.0001), but eligible patients were more likely to die (11%vs. 5%, P < 0.0001) than ineligible patients. Loss to programme was higher in men, in patients with low CD4 cell counts and low socio‐economic status and in recent time periods. Conclusions Monitoring and care in the pre‐ART time period need improvement, with greater emphasis on patients not yet eligible for ART.Keywords
This publication has 47 references indexed in Scilit:
- Implementation of free cotrimoxazole prophylaxis improves clinic retention among antiretroviral therapy-ineligible clients in KenyaAIDS, 2011
- Retention in HIV Care for Individuals Not Yet Eligible for Antiretroviral Therapy: Rural KwaZulu-Natal, South AfricaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2011
- Outcomes in patients waiting for antiretroviral treatment in the Free State Province, South Africa: prospective linkage studyAIDS, 2010
- Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmesThe Lancet, 2010
- Who starts antiretroviral therapy in Durban, South Africa?… not everyone who shouldAIDS, 2010
- Loss to Follow-Up of Adults in Public HIV Care Systems in Central Mozambique: Identifying Obstacles to TreatmentJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- Late-Disease Stage at Presentation to an HIV Clinic in the Era of Free Antiretroviral Therapy in Sub-Saharan AfricaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2009
- The impact of gender and income on survival and retention in a South African antiretroviral therapy programmeTropical Medicine & International Health, 2009
- Loss to follow-up and mortality among pregnant women referred to a community clinic for antiretroviral treatmentAIDS, 2008
- Quantifying heterogeneity in a meta-analysisStatistics in Medicine, 2002